Centre Hospitalier Universitaire de Poitiers

Recent papers from Centre Hospitalier Universitaire de Poitiers

1. Optical characterization of endoscopes for StoneSense™ compatibilityWorld Journal of Urology · 2026
2. Toxoplasma gondii genotyping in 2,467 human toxoplasmosis cases from France and other geographical origins: genetic diversity and clinical associations2026
3. Prognostic Impact of FLT3 ‐ ITD Allelic Ratio in AML Patients Treated With High‐Dose Anthracycline and a FLT3 InhibitorAmerican Journal of Hematology · 2026
4. Longitudinal trends in statin prescribing and LDL-C control prior to acute myocardial infarction (AMI) in France: we continue to “miss the mark”European Heart Journal · 2026
5. Cognitive impairment and 1-year outcomes in patients hospitalized for acute heart failure: insights from the OFICA2 cohortEuropean Heart Journal · 2026
6. Genetic Screening for Expanded FMR1 Alleles in a Moroccan Cohort With Unexplained Intellectual DisabilityJournal of Intellectual Disability Research · 2026
7. Sex-related differences in characteristics and outcome of patients with acute myocarditis: insights from the Prospective MyocarditIRM StudyEuropean Heart Journal · 2026
8. Socioeconomic disparities among patients hospitalized for acute myocardial infarction: insights from the FAST-MI 2015 registryEuropean Heart Journal · 2026
9. Rationale and design of the Cardiac MRI and Biological Samples in the Acute Phase of ST-Segment Elevation Myocardial Infarction study (the CARAMBOLE study)American Heart Journal Plus Cardiology Research and Practice · 2026
10. MiR-22-3p shapes glioblastoma radiation resistance and downregulates the DNA demethylase tumor suppressor TET1Journal of Experimental & Clinical Cancer Research · 2026
11. Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myelomaBlood Cancer Journal · 2026
12. Radiopharmaceutical Therapy with [ 177 Lu]Lu-DOTATATE in Refractory Meningiomas: Results from the French Multicenter MELUTE CohortJournal of Nuclear Medicine · 2026
13. Initial treatment strategies and outcomes across haemodynamic thresholds and risk stratification in incident systemic sclerosis–associated pulmonary arterial hypertension: a EUSTAR analysisArthritis & Rheumatology · 2026
14. Outcomes of ibrutinib plus lenalidomide combination in patients with large Bcell lymphoma refractory to or relapsing after CAR-T-cell therapy and who failed or were ineligible for bispecific antibodies: a multicenter real-world REALI-T studyHaematologica · 2026
15. Nivolumab-Ipilimumab for Localized Microsatellite Instability–High Gastric/Gastroesophageal Junction AdenocarcinomaJAMA Oncology · 2026
16. Real-World Use of Dinutuximab Beta for High-Risk Neuroblastoma in Clinical Settings in France: The QUATUOR StudyJournal of Pediatric Hematology/Oncology · 2026
17. CAR T-cell activity for autoimmune diseases across EBMT centers: an international survey on behalf of the Autoimmune Diseases Working Party and the Cellular Therapy and Immunobiology Working PartyHaematologica · 2026
18. Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trialThe Lancet · 2025
19. Subcutaneous Implantable Cardioverter-Defibrillator Therapy in WomenJACC. Clinical electrophysiology · 2026
20. Predictors of cardiac rehabilitation completion after acute myocardial infarction in young women: the French WAMIF RegistryEuropean Heart Journal Open · 2026